Navigation Links
Alpharma in Medical News

King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion

Combination to Create a Leading Specialty Pharmaceutical Company with Greater Commercialization Capabilities, Expanded Portfolio of Pain Management Products and a Strengthened Pipeline King Extends Tender Offer Through December 19, 2008 BRISTOL, Tenn. and BRIDGEWATER, N.J., Nov....

Alpharma's Reach Teach Learn Initiative Targets Youth and Consumer Awareness

...ure that honest, educated decisions are made. alpharma Inc., Animal Health announced the launch of Reach...ellinger, Global Leader, Sales & Marketing for alpharma Inc., Animal Health. "These initiatives are small ...an important role in the future of agriculture and alpharma is reaching out to help them glean a thorough unde...

Leaders from the Field of Pain Therapeutics to Discuss Latest Discoveries and Breakthroughs at Arrowhead's 3rd Annual Pain Therapeutics Summit

...amp; Critical Care Medicine, Division of Pain Medicine, formerly Chief Medical Officer, Senior Vice President Clinical Research & Medical Affairs, alpharma Inc. For more information about this conference, please visit www.arrowheadpublishers.com , or call 1-312-244-3703, ext. 4. ### Read the f...

DURECT Appoints Dr. Joseph Stauffer as Chief Medical Officer and Executive Vice President, Corporate Strategy

...rch and medical affairs for pain products while at alpharma and Abbott, and first-hand experience with the reg...(TM) and other programs." Dr. Stauffer was at alpharma Inc. from 2004 to 2009, where his latest position prior to the acquisition of alpharma by King Pharmaceuticals was as Chief Medical Offic...

Irvine Pharmaceutical Services Enhances Staff, Prepares for Innovative Expansion

...nderstanding and knowledge of the company as well as pharmaceutical development. His previous positions at highly reputable organizations such as PPD, alpharma (Actavis), Solvay Pharmaceuticals and Solvay Animal Health, to name a few, has helped develop his expertise in a range of areas, including chromatogra...

National Family Partnership Designates October 27th 'Lock Your Meds' Day

...ve social activities for youth. About Alpharma alpharma Inc. (NYSE: ALO ) is a global specialty pharmaceu...ship positions in products for humans and animals. alpharma is presently active in more than 80 countries. alpharma has a growing branded pharmaceutical franchise in ...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes

...als (Nasdaq: VRTX ) Add Adolor Corp. (Nasdaq: ADLR ) ALLOS THERAPEUTICS INC. (Nasdaq: ALTH ) Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY ) alpharma Inc. (NYSE: ALO ) Altus Pharmaceuticals Inc. (Nasdaq: ALTU ) AMAG Pharmaceuticals Inc. (Nasdaq: AMAG ) ANGIOTECH PHARMACEUTICALS (Nasdaq: AN...

Cardinal Health Taps Teva Executive George Barrett to Lead Healthcare Supply Chain Services Sector

...tt served as CEO of Diad Research, a technology start-up. From 1990 to 1997, he held various senior management positions with pharmaceutical companies alpharma Inc. and NMC Laboratories. Barrett is a past chairman of the Generic Pharmaceutical Association and is on the board of ambassadors of Johns Hopkins Sc...

KADIAN Efficacy Not Affected by Alcohol Consumption

...e extended-release) Capsules have been released by alpharma Inc. (NYSE: ALO), a leading pharmaceutical company... Results of this pharmacokinetic study, which alpharma conducted in response to a request by the U.S. Foo...ce President, Clinical Research & Medical Affairs, alpharma Pharmaceuticals Division Inc. "We believe this inf...
Alpharma in Medical Technology

Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting

...IDGEWATER, N.J., Sept. 9 /PRNewswire-FirstCall/ -- alpharma Inc. (NYSE: ALO ), a global specialty pharmaceuti...ogic abuse-deterrent, extended-release opioid that alpharma is developing for the treatment of moderate to sev... President of Clinical Research & Medical Affairs, alpharma Pharmaceuticals. "We look forward to collaborating...

Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session

... TAMPA, Fla., May 8 /PRNewswire-FirstCall/ -- alpharma Inc. (NYSE: ALO ), a global specialty pharmaceuti...ogic abuse-deterrent, extended-release opioid that alpharma is developing for the treatment of moderate to sev...eating patients with chronic pain." On April 21, alpharma announced that it withdrew its New Drug Applicatio...

Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions

...AID TAMPA, Fla., May 8 /PRNewswire-FirstCall/ -- alpharma Inc. (NYSE: ALO ), a leading global specialty pha...lerability and positive pharmacokinetic profile of alpharma Pharmaceuticals' FLECTOR(R) Patch (diclofenac epol... President, Clinical Research and Medical Affairs, alpharma Pharmaceuticals. "In addition to supporting the ef...

Alpharma Presents Positive Pharmacokinetic Study Results of Its Investigational Abuse-Deterrent, Extended-Release Opioid

...h & Medical Affairs and Senior Vice President, alpharma Pharmaceuticals LLC. "We are committed to offering...="http://www.kadian.com/">www.KADIAN.com . About alpharma alpharma Inc. is a global specialty pharmaceutical company ...
Alpharma in Biological Technology

DURECT's Collaboration With Alpharma Clears HSR Review and Is Effective

CUPERTINO, Calif., Oct. 29 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX ) announced today that the previously announced development and license agreement with Alpharma Ireland Limited, an affiliate of Alpharma Inc. (NYSE: ALO ), granting such party the exclusive worldwide right...

DURECT Corporation Announces Third Quarter 2008 Financial Results

... receipt of a $20 million upfront license fee from alpharma in the fourth quarter of 2008 and a review of proj...r us was the establishment of a collaboration with alpharma to develop and commercialize our ELADUR(TM) bupiva...ered into a development and license agreement with alpharma Ireland Ltd., an affiliate of Alpharma, Inc., gran...

Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes

... ALKERMES INC. (NASDAQ: ALKS ) ALLERGAN INC. (NYSE: AGN ) ALLOS THERAPEUTICS INC. (NASDAQ: ALTH ) ALNYLAM PHARMACEUTICALS INC. (NASDAQ: ALNY ) alpharma INC. (NYSE: ALO ) ALTUS PHARMACEUTICALS INC. (NASDAQ: ALTU ) AMAG PHARMACEUTICALS INC. (NASDAQ: AMAG ) ANGIOTECH PHARMACEUTICALS INC. (TSE: ANP)...

Informed Medical Communications Appoints New Chief Financial Officer

...shares doubled and the company saw a dramatic improvement in cash flow. Prior to this, Marchio helped finance the domestic and international growth of alpharma from under $300MM in sales (1992) to approximately $1.3B (2005) while building treasury, tax, risk management and benefit finance systems as their Vic...

Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales

...o market, specifically with testing products and in the diabetes arena." Prior to joining Synvista, Mr. Tantillo was Director Strategic Marketing at alpharma Pharmaceuticals. From 2006 to 2007, he was U.S. Marketing Director at Mayne Pharma, which was acquired by Hospira. Prior to that, from 2004 to 2005 he...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)

...uticals (Nasdaq: VRTX ) Add Adolor Corp. (Nasdaq: ADLR ) ALLOS THERAPEUTICS INC. (Nasdaq: ALTH ) Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY ) alpharma Inc. (NYSE: ALO ) Altus Pharmaceuticals Inc. (Nasdaq: ALTU ) AMAG Pharmaceuticals Inc. (Nasdaq: AMAG ) ANGIOTECH PHARMACEUTICALS (Nasdaq: ANPI ...
Other Tags
(Date:7/31/2015)... ... ... Girl Scouts of Historic Georgia and Peach State Health Plan are teaming ... Friend First" program. Representatives from Peach State Health Plan presented a $10,000 check for ... our parent company, Centene Corporation, are dedicated to raising anti-bullying awareness. We are very ...
(Date:7/31/2015)... , ... July 31, 2015 , ... The 2015 ALS ... Major League Baseball and the Boston Red Sox honor Ice Bucket co-founders Pat Quinn ... MLB is donating $100,000 to further collaborative efforts among the ALS organizations to find ...
(Date:7/31/2015)... Toledo, Ohio (PRWEB) , ... July 31, 2015 ... ... U.S. District Court for the Northern District of Ohio, Western Division (Case No. ... complaint (Case No: 3:15-cv-00397), the women experienced spontaneous migration of their Implanon® implants, ...
(Date:7/31/2015)... NY and Rockport, ME (PRWEB) , ... July 31, 2015 , ... The alarm was ... op. , Glancing out of the window, he recalled that his equipment was set ... Chrystie Street tower, he jumped out of bed. , The photo speaks for itself. ...
(Date:7/31/2015)... ... July 31, 2015 , ... Patients with higher levels ... a study published today in Nature Communications and led by researchers from the Icahn ... that variations in the gene RTN1 led to greater production of the related RNT1 ...
Breaking Medicine News(10 mins):Health News:Peach State Health Plan Presents $10,000 Check for “Be a Friend First” Anti-Bullying Program to Local Girl Scouts 2Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 2Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 3Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 4Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 2Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 3Health News:Mount Sinai Researchers Find Key Gene Drives Kidney Disease Severity 2Health News:Mount Sinai Researchers Find Key Gene Drives Kidney Disease Severity 3
(Date:7/31/2015)... 2015 BGI llevará a cabo la 10ª Conferencia ... 25 de octubre de 2015, en Shenzhen, ... décimo aniversario este año. Desde su inauguración en 2006, ... anuales más influyentes del mundo en los campos de ... más dinámicas, entusiastas y amenas. ICG-10 se ...
(Date:7/31/2015)... , 31 de julio de 2015 La 10 ... se celebrará por medio de BGI del 22 al 25 de ... Este año, la conferencia celebra su décimo ... ha convertido en una de las reuniones anuales más influyentes ... de las reuniones más dinámicas, entusiastas y mejores a nivel ...
(Date:7/31/2015)... SHENZHEN, China , July 31, 2015 The ... ) will be held by BGI from October 22-25, 2015, in ... The conference is celebrating its 10 th ... become one of the world,s most influential annual meetings in ... enthusiastic, and enjoyable scientific gatherings. ICG-10 focuses ...
Breaking Biology News(10 mins):La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3The 10th International Conference on Genomics (ICG-10) to Open in October 2
Other Contents